Fig. 1
From: PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Expression of PDCL3 in pan-cancer tissues. A Analysis of PDCL3 expression in various cancers using the TIMER database. B Analysis of the differential protein expression of PDCL3 in tumors and normal tissues using the CPTAC database. C Expression of PDCL3 in different cancers and its association with prognosis. D Kaplan–Meier survival curves for patients with different types of cancer. *p value < 0.05; **p value < 0.01; ***p value < 0.001 (Student’s t test)